Aurobindo Pharma Limited — Ondansetron Exporter Profile
Indian Pharmaceutical Exporter · #4 for Ondansetron · $41.0M export value · DGFT Verified
Aurobindo Pharma Limited is the #4 Indian exporter of Ondansetron with $41.0M in export value and 244 verified shipments. Aurobindo Pharma Limited holds a 25.8% market share in Ondansetron exports across 6 countries. The company exports 81 pharmaceutical products worth $1.1B across 18 therapeutic categories.
Aurobindo Pharma Limited — Ondansetron Export Profile: Buyers & Destinations
Where Does Aurobindo Pharma Limited Export Ondansetron?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $26.6M | 833 | 93.8% |
| UNITED KINGDOM | $546.1K | 43 | 1.9% |
| UNITED STATES OF AMERICA | $472.9K | 13 | 1.7% |
| CANADA | $351.3K | 13 | 1.2% |
| MALTA | $162.9K | 59 | 0.6% |
| ISRAEL | $150.0K | 3 | 0.5% |
| TANZANIA | $20.9K | 6 | 0.1% |
| ETHIOPIA | $19.0K | 3 | 0.1% |
| IRAQ | $11.6K | 1 | 0.0% |
| NETHERLANDS | $9.5K | 3 | 0.0% |
Aurobindo Pharma Limited exports Ondansetron to 15 countries. The largest destination is UNITED STATES accounting for 93.8% of Aurobindo Pharma Limited's Ondansetron shipments, followed by UNITED KINGDOM (1.9%) and UNITED STATES OF AMERICA (1.7%). These destinations reflect Aurobindo Pharma Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Ondansetron from Aurobindo Pharma Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| RISING PHARMA HOLDINGS, INC. ,. | UNITED STATES | $4.5M | 112 |
| NORTHSTAR DISTRIBUTION CENTER 8912 | UNITED STATES | $4.3M | 156 |
| AUROLOGISTICS LLC, (AUROBINDO PHARM | UNITED STATES | $3.6M | 84 |
| RISING PHARMA HOLDINGS, INC. | UNITED STATES | $3.2M | 160 |
| AUROLOGISTICS LLC (AUROBINDO PHARMA | UNITED STATES | $2.1M | 54 |
| RISING PHARMA HOLDINGS INC | UNITED STATES | $2.0M | 62 |
| RISING PHARMA HOLDINGS, INC. , | UNITED STATES | $1.8M | 51 |
| AUROLOGISTICS LLC | UNITED STATES | $1.5M | 47 |
| AUROLOGISTICS LLC AUROBINDO PHARM | UNITED STATES | $1.3M | 30 |
| AUROLOGISTICS LLC(AUROBINDO PHARMA | UNITED STATES | $1.1M | 33 |
Aurobindo Pharma Limited supplies Ondansetron to 60 buyers globally. The largest buyer is RISING PHARMA HOLDINGS, INC. ,. (UNITED STATES), followed by NORTHSTAR DISTRIBUTION CENTER 8912 (UNITED STATES) and AUROLOGISTICS LLC, (AUROBINDO PHARM (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Ondansetron Export Value and How Much Does Aurobindo Pharma Limited Contribute?
India exported $100.2M worth of Ondansetron through 8,469 shipments from 537 suppliers to 157 countries, serving 1,636 buyers globally. Aurobindo Pharma Limited contributes $41.0M to this total, accounting for 25.8% of India's Ondansetron exports. Aurobindo Pharma Limited ships Ondansetron to 15 countries through 60 buyers.
What Is the Average Shipment Value for Aurobindo Pharma Limited's Ondansetron Exports?
Aurobindo Pharma Limited's average Ondansetron shipment value is $168.1K per consignment, based on 244 shipments totaling $41.0M. The largest destination is UNITED STATES (93.8% of Aurobindo Pharma Limited's Ondansetron exports).
How Does Aurobindo Pharma Limited Compare to Other Indian Ondansetron Exporters?
Aurobindo Pharma Limited ranks #4 among 537 Indian Ondansetron exporters with a 25.8% market share. The top 3 exporters are AUROBINDO PHARMA LTD ($31.2M), GLENMARK PHARMACEUTICALS LIMITED ($15.9M), BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED ($10.8M). Aurobindo Pharma Limited processed 244 shipments to 6 destination countries.
What Ondansetron Formulations Does Aurobindo Pharma Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ONDANSETRON ORALLY DISINTEGRATING TABLET | $6.0M | 161 |
| ONDANSETRON HCL TABLETS 4MG (ONDANSETRON | $1.6M | 38 |
| ONDANSETRON TABLETS 8MG (89664X30'S) | $1.2M | 24 |
| ONDANSETRON ORALLY DISINTEGRATING TABLETS 4MG (115200X30'S) | $884.1K | 26 |
| ONDANSETRON HCL TABLETS 8MG (ONDANSETRON | $849.0K | 33 |
| ONDANSETRON HCL TABLETS 4MG (ONDANSETRONORALLY DISINTEGRATING TABLETS USP 4MG)(115200X3X10'S PACK) | $352.1K | 10 |
| ONDANSETRON HCL TABLETS 4MG (181584X30' | $350.0K | 7 |
| ONDANSETRON ORALLY DISINTEGRATING TABLETS 4MG 3X10'S (ONDANSETRON ORALLY DISINTEGRATING | $347.3K | 9 |
| ONDANSETRON HCL TABLETS 4MG (ONDANSETRONTABLETS USP 4MG) 30'S | $316.2K | 9 |
| ONDANSETRON ORALLY DISINTEGRATING TABLETS 4MG 115200X30'S | $250.0K | 5 |
Aurobindo Pharma Limited exports 446 distinct Ondansetron formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ONDANSETRON ORALLY DISINTEGRATING TABLET with 161 shipments worth $6.0M.
Regulatory Requirements: Exporting Ondansetron to Key Markets
What Aurobindo Pharma Limited must comply with to export Ondansetron to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Aurobindo Pharma Limited Compare to Nearest Ondansetron Exporters?
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | GLENMARK PHARMACEUTICALS LIMITED | $15.9M | 635 | 5 | $25.1K |
| 3 | BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED | $10.8M | 272 | 19 | $39.7K |
| 4 | AUROBINDO PHARMA LIMITED ★ | $9.8M | 244 | 6 | $40.1K |
| 6 | DR.REDDY'S LABORATORIES LTD | $5.2M | 213 | 7 | $24.4K |
| 5 | GLAND PHARMA LIMITED | $5.0M | 101 | 2 | $50.0K |
Aurobindo Pharma Limited ranks #4 among 537 Indian Ondansetron exporters. Average shipment value of $40.1K compared to the market average of $186.5K. The closest competitors by value are GLENMARK PHARMACEUTICALS LIMITED and BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED.
Which Indian Ports Ship Ondansetron Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 1,058 | 12.5% |
| NHAVA SHEVA SEA (INNSA1) | 1,026 | 12.1% |
| SAHAR AIR | 993 | 11.7% |
| HYDERABAD ICD (INSNF6) | 509 | 6.0% |
| HYDERABAD ICD | 448 | 5.3% |
| JNPT/ NHAVA SHEVA SEA | 343 | 4.1% |
| DELHI AIR CARGO ACC (INDEL4) | 265 | 3.1% |
| AHEMDABAD AIR ACC (INAMD4) | 224 | 2.6% |
What Other Gastrointestinal Products Does Aurobindo Pharma Limited Export?
Aurobindo Pharma Limited also exports these gastrointestinal products. Each links to the detailed product page.
About Aurobindo Pharma Limited
Aurobindo Pharma Limited exports 81 products worth $1.1B. Beyond Ondansetron, top products include Amoxicillin, Potassium, Pantoprazole, Clopidogrel, Rosuvastatin. View the complete Aurobindo Pharma Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ondansetron — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ondansetron shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Aurobindo Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 985 individual customs records matching Aurobindo Pharma Limited exporting Ondansetron, covering 446 formulations to 15 countries via 60 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 157+ countries, 1,636+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ondansetron Export Data from Aurobindo Pharma Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Aurobindo Pharma Limited's Ondansetron exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Aurobindo Pharma Limited
Full Company Profile →
81 products · $1.1B total trade · 18 categories
Ondansetron Stats
Company Overview
Top Products by Aurobindo Pharma Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Aurobindo Pharma Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ondansetron. For current shipment-level data, contact TransData Nexus.